NEJM Interview: Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices. - podcast episode cover

NEJM Interview: Dr. Peter Neumann on the use of various new value-based frameworks for assessing drugs and drug prices.

Dec 30, 20158 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Peter Neumann is director of the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. P.J. Neumann and J.T. Cohen. Measuring the Value of Prescription Drugs. N Engl J Med 2015;373:2595-7. R.C. Young. Value-Based Cancer Care. N Engl J Med 2015;373:2593-5.
For the best experience, listen in Metacast app for iOS or Android